Published in
Elsevier, Critical Reviews in Oncology/Hematology, (196), p. 104324, 2024
DOI: 10.1016/j.critrevonc.2024.104324
Links
Tools
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions
Journal article published in 2024 by
Riccardo Gerosa,
Rita De Sanctis 
,
Flavia Jacobs,
Chiara Benvenuti,
Mariangela Gaudio,
Giuseppe Saltalamacchia,
Rosalba Torrisi,
Giovanna Masci,
Chiara Miggiano,
Francesco Agustoni,
Paolo Pedrazzoli,
Armando Santoro ,
Alberto Zambelli
,
Flavia Jacobs,
Chiara Benvenuti,
Mariangela Gaudio,
Giuseppe Saltalamacchia,
Rosalba Torrisi,
Giovanna Masci,
Chiara Miggiano,
Francesco Agustoni,
Paolo Pedrazzoli,
Armando Santoro ,
Alberto Zambelli
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 